We're opening soonWe're opening soon. Sign up and get notified the moment we go live.
Get notified when we launch
10% off the entire range with codeLAUNCH10
Ordered before 16:00 = shipped the same day · 1-2 business days delivery within the Netherlands · Discreet shipping · Free shipping from €75 (NL/BE) / €150 (EU)
Research guide

TB-500 (Thymosin β4 fragment)

TB-500 is a synthetic fragment of Thymosin β4, an actin-binding protein. Research focuses on cell migration, tissue repair and angiogenesis in preclinical models.

Shipped from the Netherlands≥ 99% purity

What is TB-500 (Thymosin β4 fragment)?

TB-500 is a synthetic fragment of Thymosin β4, an actin-binding protein. Research focuses on cell migration, tissue repair and angiogenesis in preclinical models. This page is intended solely as an informational research guide for laboratory applications (Research Use Only).

Mechanism (preclinical)

Contains the actin-binding sequence of Thymosin β4 and affects the cytoskeleton, cell migration and vascular formation in vitro.

Research areas

  • Tissue repair and regeneration
  • Cell migration and cytoskeleton
  • Angiogenesis
  • Tendon, muscle and skin research (preclinical)

Specifications

Molecular weight
≈ 4,963 Da
Purity
≥ 99%
Form
Lyophilised powder
Included
3 ml bacteriostatic water

Storage and reconstitution

Dry (lyophilised) powder can be stored long-term at -20 to -80 °C in an airtight, opaque container. After reconstitution with bacteriostatic water the solution must be refrigerated at 2 to 8 °C and protected from light.

Order TB-500 (Thymosin β4 fragment) from Europa Peptides

Europa Peptides supplies TB-500 (Thymosin β4 fragment) as lyophilised powder with ≥ 99% purity - 3 ml bacteriostatic water included. Shipped from our Netherlands warehouse. Orders placed before 16:00 on a business day ship the same day. For laboratory research only (RUO).

Important (RUO): This product is intended solely for in-vitro/in-vivo laboratory research by qualified scientific personnel. All information above describes associations from peer-reviewed preclinical literature and does not constitute a recommendation for any other application.